DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Parenteral Drugs (India) Ltd (PDPL) share price today?

Parenteral Drugs (India) Ltd (PDPL) is trading at ₹4.25 on the NSE, down 4.49% on the day. Source: DocStoX.

What is the market capitalisation of Parenteral Drugs (India) Ltd?

Parenteral Drugs (India) Ltd has a market capitalisation of approximately ₹12 crore.

Parenteral Drugs (India) Ltd

₹4.25▼ -0.20 (-4.49%)

PDPL·NSE·Healthcare

Market Cap

11.96 Cr

PE Ratio

—

Volume

555

Day High - Low

4.25 - 4.25

52W High-Low

—

₹4.25▼ -0.20 (-4.49%)

Market Cap11.96 Cr

PE Ratio—

Volume555

Day High - Low4.25 - 4.25

52W High-Low—

Parenteral Drugs (India) Ltd (PDPL): company summary

Parenteral Drugs (India) Ltd (PDPL) is a micro-cap Healthcare company valued at ₹12 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.

Recent price move: Parenteral Drugs (India) Ltd last traded at ₹4.25, down 4.49% on the day.
Financial performance: Revenue has been shrinking at -37.0% a year over three years.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Last traded ₹4.25 on 4 Dec 2022 (1414 days ago). Not a live price.

DocStoX Score

0.0/10

Poor

Fair Value

ROE

—

P/E

—

Debt / Equity

—

Industry

Healthcare

Pharmaceuticals & Biotechnology

Overall View

Poor

Price performance

DocStoX take

Held back by growth (0.0). The latest financials on file are more than 18 months old, so treat the fundamental measures with caution. Scored on 3 of 5 measures.

DocStoX score

Low confidence

0.0

/10

Poor

Quality

Weak

Net margin -950.0%

Valuation

No data

No valuation multiples

Growth

Flat

Revenue -48.9% 5Y CAGR

Risk

Moderate

₹12 cr market cap

Momentum

No data

No technical indicators

Scored on 3 of 5 measures — the rest have no data for this company.

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹4

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹12 Cr

52W High / Low

—

Dividend Yield

—

Promoter Holding

73.29%

EPS (TTM)

₹-25.61

Book Value

—

Key highlights

Revenue shrinking 49% a year
Loss-making in some of the last 5 years

0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals & Biotechnology

Explore Parenteral Drugs (India) Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Parenteral Drugs (India) Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Parenteral Drugs (India) Ltd with peers

Parenteral Drugs (India) Ltd vs Sun Pharmaceutical Industries Limited Parenteral Drugs (India) Ltd vs Divi's Laboratories Limited Parenteral Drugs (India) Ltd vs Torrent Pharmaceuticals Limited Parenteral Drugs (India) Ltd vs Apollo Hospitals Enterprise Limited Parenteral Drugs (India) Ltd vs Zydus Lifesciences Limited Parenteral Drugs (India) Ltd vs Laurus Labs Limited

Related tools & concepts

Value Parenteral Drugs (India) Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

PDPL newsLatest coverage & filings Open screenerFilter the whole market